Clinical Trial Kits Industry Overview
The global clinical trial kits market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.
Clinical Trial Kits Market Segmentation
Grand View Research has segmented the global clinical trial kits market on the basis of service, phase, and region:
Based on the Service Insights, the market is segmented into Kitting Solutions, Drugs kits, Sample collection kits, Logistics, Transportation, Warehousing Storage, Others.
- The logistics segment dominated the market for clinical trial kits and accounted for the largest revenue share of 54.9% in 2020. Clinical trial size continues to grow, causing a rippling effect on pharmaceutical packaging.
- Secondary package design is becoming more important in order to reduce the risk of product damage or activation during transportation. As authorities push the pharmaceutical sector to examine a bigger number of people, studies are growing bigger.
- The logistic team's primary goal is to transfer samples to the analysis lab as fast and effectively as possible. It also offers both primary and secondary packaging services for a variety of container types. They also create patient kits and offer full kit labeling and printing services.
- The clinical trial logistics team is responsible for trial supply randomization, blinding and unblinding, and rescue medicine packing and labeling. They also offer a complete comparator sourcing service, as well as release testing, re-packaging, and labeling for clinical trial usage.
Based on the Phase Insights, the market is segmented into Phase I, Phase II, Phase III, Phase IV.
- The phase III segment dominated the market for clinical trial kits and accounted for the largest revenue share of 53.3% in 2020 and is likely to remain dominant in the coming future.
- The major factor that influences the market for phase III is the purpose of testing pharmaceutical products in humans to validate the therapeutic efficacy observed in Phase II on a large number of patients with a specific disease. This is the transition period from chemical to drug state.
- The objective of phase III is to demonstrate the new medicine's or vaccine's safety and efficacy in the average patient who will use it, confirm effective dosage levels, and discover adverse effects or reasons why the therapy should not be given to persons with another illness.
Clinical Trial Kits Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa (MEA)
Key Companies Profile Market Share Insights
Key market players are undertaking various business strategies, such as forming strategic alliances, to expand their geographical reach and capture a big market share.
Some prominent players in the global clinical trial kits market include
- Brooks life science
- Q2 solutions
- Patheon (Thermo fisher scientific)
- LabCorp drug development
- Charles river laboratories
- LabConnect
- Almac group
- Precision medicine group
- Cerba research
- Alpha laboratories
- Marken
- Clinigen
Order a free sample PDF of the Clinical Trial Kits Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
